Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Biocryst Pharmaceuticals, Inc.
Erianne Leatherman
| Apr 14, 2017
BioCryst reports encouraging results in Phase 2 APeX-1 trial of hereditary angioedema treatment
Trending
+
Marketing
Patient Daily
| Apr 22, 2024
Medfluence Senior Director of Business Development on healthcare marketing: 'Patient experience matters more than ever in patient acquisition'
+
Pharmaceuticals
Patient Daily
| Apr 24, 2024
Researchers Look for Long-Term Hearing Loss Treatments
+
Pharmaceuticals
Patient Daily
| Apr 24, 2024
American Lung Association Report: Utah Receives Poor Grades for Ozone and Particle Pollution
+
Pharmaceuticals
Patient Daily
| Apr 23, 2024
Kentucky Father with Terminal Lung Cancer Now Cancer-Free After Innovative Double-Lung Transplant at Northwestern Medicine